• iphepha_ibhena

Iindaba

UFluxergy wayelilungu eliseka iNkqubo yeLungu loShishino (IPP) iWyss Diagnostic Accelerator (Wyss DxA).I-Wyss DxA linyathelo le-Wyss Institute kwiYunivesithi yaseHarvard lokudala kunye nokuhambisa iteknoloji yoxilongo olunempumelelo ukuhlangabezana neemfuno zekliniki ekuhlolweni, ukuxilongwa, ukuxilongwa, kunye nonyango.Ngokuthatha inxaxheba kwi-IPP, iFluxergy isebenzisana noogqirha ababalaseleyo, abaphandi, iinjineli, ii-arhente zenkxaso-mali, ii-philanthropists, ii-arhente zikarhulumente, kunye namaqabane eshishini.
"Umlinganiselo wempumelelo ye-Wyss Diagnostic Accelerator isindisa ubomi ngokubonelela ngoxilongo oluchanekileyo kunye nolufikelelekayo, kwaye oko kuyinjongo yethu," kusho uDkt Rushdi Ahmad, iNtloko ye-Wyss DxA.
I-Wyss DxA ikhokelwa ngu-Ahmad kunye noDkt David Walt.UWalt lilungu elikhokelayo kwi-Wyss Institute, unjingalwazi wezifundo ngezifo kwiSibhedlele saseBrigham nakwiSibhedlele sabaseTyhini, kunye nomseki wenzululwazi weenkampani ezininzi zenzululwazi yobomi.Ngokuthatha inxaxheba kwiprogram, i-Fluxergy iya kusebenza ngaphakathi kwe-IPP ukuququzelela ukufunyanwa, ukuphuhliswa kunye nokuhanjiswa kwezisombululo zokuxilonga kwiindawo apho imfuno ingafezeki.
“Emva kokudibana kwam okokuqala namaqabane okuqala, ndavuya kakhulu.Sinendawo egcwele ubunzima bezenzululwazi kunye nezorhwebo ukuphumeza utshintsho, ngakumbi ukufanisa iimfuno ezingafezekiyo kunye nobuchwepheshe obufunwayo.Ithuba lokujoyina iqela eliqhutywa ngamava omanyano lwabantu abazizityebi, abanomdla likhethekile ngobuchwephesha obahlukeneyo: izicelo kwimpilo yabantu, iyeza lonyango lwezilwanyana kunye nokhuseleko lokutya, ubukho behlabathi kuzo zonke iimarike kunye nokugubungela i-telemedicine, ukuxilongwa, ukufunyanwa kwamayeza. kunye nempilo yedijithali, "utshilo uTej Patel, i-CEO kunye nomseki weFluxergy.
I-Fluxergy ijolise ekusebenziseni iqonga layo lokuxilonga i-multi-modal njengeqabane le-OEM ukuvelisa iipaneli zovavanyo ezininzi ze-ohm ezidibanisa ukudibanisa iiprotheni, iikopi kunye ne-metabolites kwiisiginitsha ezizodwa ukwazisa ngcono izigulane malunga neziphumo zonyango.Imizekelo yezicelo zempilo yabantu inokubonwa kwizifo ezosulelayo, izifo zegazi ezingapheliyo, umhlaza, i-sepsis, kunye nesifo sezintso ezingapheliyo.Okwangoku, izixhobo zokhathalelo lwempilo zinokulinganiselwa ekumiseleni uhlobo olunye lweparamitha (oko kukuthi, i-immunoassay, ikhemistri, okanye iPCR).Iinkqubo eziguquguqukayo ze-Fluxergy ziyilelwe ukwenza i-PCR, i-immunoassay, i-biochemistry kunye nokubala kweeseli kwiqonga elinye elisebenziseka lula.Kukhathalelo lwempilo, i-Fluxergy ijolise ekuncedeni ukuphucula iiphaneli zovavanyo lwe-syndromic kunye nemeko kwaye zibenze zifumaneke ukuba zisetyenziswe kwiikliniki ezincinci, kwiiofisi zoogqirha, kumakhaya abantu abalupheleyo kunye nabathengi kwiimvavanyo ezintsonkothileyo, ukusuka kwiiphaneli ze-metabolic ngokubanzi ukuya kwiimvavanyo zokuhlola i-sepsis.Oku kukwandiswa kwesiseko selabhoratri esisembindini esiza kuququzelela ukuthathwa kwezigqibo zekliniki ngokukhawuleza okusekwe kulwazi lwaselabhoratri.
UDkt Ahmed wagqiba intlanganiso yokuphela konyaka ngokuthi, "Kwi-Wyss Diagnostic Accelerator, eli qela linombono ongenakulinganiswa kunye nowodwa wokwenza ukuxilongwa kufikeleleke kumntu wonke."
I-Fluxergy yinkampani yesixhobo sonyango esigxile kwitekhnoloji yokufumanisa indawo yokusetyenziswa ukubonelela ngoxilongo olufikelelekayo kuyo nayiphi na imeko.Inkqubo ye-Fluxergy isebenzisa i-microfluidics yobunini kunye nenkqubo ye-sensor edibeneyo edibeneyo yokudala i-platform yokuvavanya i-multimodal eguquguqukayo kunye neendleko.I-Fluxergy yi-ISO 13485 kunye ne-MDSAP eqinisekisiweyo kwimveliso ye-IVD. Ukwenziwa kweFluxergy's kunye nekhampasi ye-R&D ithatha indawo ye-90,000 sq.ft. Ukwenziwa kweFluxergy's kunye nekhampasi ye-R&D ithatha indawo ye-90,000 sq.ft.Ikhampasi yokwenziwa kunye nophando yeFluxergy ithatha indawo eyi-90,000 sq. ft.Ikhampasi yokuvelisa kunye nophando yeFluxergy igubungela i-90,000 yeenyawo zesikwere.eIrvine, eCalifornia.I-Fluxergy Europe i-GMBH isekwe e-Aschaffenburg, eJamani.I-Fluxergy Inc. yasekwa kwi-2013 kunye nenkxaso yemali yomtyalo-mali okhokelayo kunye nomseki we-Kingston Technology, uJohn Tu.
I-Fluxergy Diagnostic Test System iqukethe iKhadi le-Fluxergy, i-cartridge yokuvavanya i-lab-on-a-chip, i-Fluxergy analyzer, kunye ne-software ye-Fluxergy Works eqhuba inkqubo yokuvavanya ukujonga nokutolika idatha yovavanyo.Amakhadi e-Fluxergy aneendlela ezininzi (okuthetha ukuba iintlobo ezahlukeneyo zovavanyo lokuxilonga zinokwenziwa ngaxeshanye, njenge-PCR, i-immunochemistry, i-chemistry, njl.njl.) kwaye zenziwa kwaye ziyilwe kusetyenziswa ibhodi yesekethe eprintiweyo (PCB), ibenza babe ngokugqithisileyo. isebenza kakuhle emalini.kunye nokwandiswa.Microfluidics.I-Fluxergy Works ivumela imibutho ukuba idibanise izixhobo ezininzi kwilifu njengoko inethiwekhi inokuxhasa.
I-Fluxergy POC PCR Test Kit COVID-19 ifumaneka kuphela ukuba ithengwe kwimarike ye-EU kunye nayo nayiphi na enye imakethi eyamkela ukumakishwa kwe-CE njengolwamkelo olusemthethweni olusemthethweni.
I-Fluxergy ikwaphuhlisa iphaneli yokuphefumla yasimahla ye-CLIA, ipaneli yokukrala, kwaye ithengisa iimveliso ezininzi kwi-equine yezilwanyana kunye neemarike zokhuseleko lokutya.
Qhagamshelana nombhali: Ulwazi loQhagamshelwano kunye nolwazi olukhoyo lwentlalo ludweliswe kwikona ephezulu ngasekunene kuzo zonke iindaba ezishicilelweyo.
© Copyright 1997-2015, Vocus PRW Holdings, LLC.I-Vocus, i-PRWeb kunye ne- Publicity Wire ziimpawu zorhwebo okanye iimpawu zorhwebo ezibhalisiweyo zeVocus, Inc. okanye iVocus PRW Holdings, LLC.


Ixesha lokuposa: Sep-11-2022